An Early Phase 1 interventional study of [C-11] and NOP-1A in Alcohol Use Disorder, sponsored by Rajesh Narendran. Completed at 1 site in United States. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-07-11.
Sponsored by Rajesh Narendran · Early Phase 1, Interventional, and Basic science
The goal of this study is to compare [C-11]NOP-1A binding in recently abstinent alcohol use disorders and controls
This will allow for understanding brain stress and antistress mechanisms that underlie abuse of alcohol in humans
[A] Alcohol use disorders (AUD)
Inclusion Criteria:
Exclusion Criteria:
[B]Healthy controls
Inclusion Criteria:
Exclusion Criteria:
\[C-11\]NOP-1A PET Scan
Radiation: [C-11] · Drug: NOP-1A
\[C-11\]NOP-1A PET Scan
Radiation: [C-11] · Drug: NOP-1A
Radiolabel
Tracer
[C-11]NOP-1A VT
VT-Volume of distribution expressed relative to total plasma
Time frame: Baseline
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Rajesh Narendran